Invention Grant
- Patent Title: Injection paradigm for administration of botulinum toxins
-
Application No.: US13075485Application Date: 2011-03-30
-
Publication No.: US08501195B2Publication Date: 2013-08-06
- Inventor: Catherine C. Turkel , Mitchell F. Brin , Sheena K. Aurora , David W. Dodick
- Applicant: Catherine C. Turkel , Mitchell F. Brin , Sheena K. Aurora , David W. Dodick
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agent Brigitte Phan; Ted Chan; Debra Condino
- Main IPC: A61K39/08
- IPC: A61K39/08 ; A61P25/00
Abstract:
Disorders such as headaches can be treated by administration of a botulinum toxin to a patient suffering therefrom, such as a migraine headache. A combined a fixed site/fixed dose and an optional follow the pain variable dosage and injection site paradigm is disclosed for optimizing clinical effectiveness of botulinum toxin administration for patients suffering headache, particularly chronic migraine.
Public/Granted literature
- US20120053126A1 Injection Paradigm for Administration of Botulinum Toxins Public/Granted day:2012-03-01
Information query
